Scryb Inc. Stock

Equities

SCYB

CA81111V1076

Advanced Medical Equipment & Technology

Market Closed - Canadian Securities Exchange 02:27:44 2024-04-19 pm EDT 5-day change 1st Jan Change
0.03 CAD +20.00% Intraday chart for Scryb Inc. 0.00% +50.00%
Sales 2022 0.67 0.92 Sales 2023 1.59 2.2 Capitalization 12.86M 17.73M
Net income 2022 -11M -15.16M Net income 2023 -19M -26.18M EV / Sales 2022 43,110,831 x
Net Debt 2022 68.24K 94.03K Net cash position 2023 30.74K 42.36K EV / Sales 2023 8,054,868 x
P/E ratio 2022
-2.58 x
P/E ratio 2023
-0.63 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 95.98%
More Fundamentals * Assessed data
Dynamic Chart
Scryb Inc. announced that it expects to receive CAD 1.5 million in funding CI
Scryb Inc. Announces Board of Directors Changes CI
Scryb Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023 CI
Scryb Inc Announces the Development of A New Artificial Intelligence Software Product, to Enhance Ai Safety and Trustworthiness for Enterprises That Are Managing Multiple AI Systems, and Provide Management Tools for Compliance with Impending Ai Regulation CI
Scryb Inc. Reports Earnings Results for the Full Year Ended September 30, 2023 CI
Scryb Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2023 CI
Scryb Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2023 CI
Scryb Inc. announced that it has received CAD 2.165 million in funding CI
Scryb Inc. announced that it expects to receive CAD 5 million in funding CI
Scryb Inc. Reports Earnings Results for the First Quarter Ended December 31, 2022 CI
Scryb Inc. Reports Earnings Results for the Full Year Ended September 30, 2022 CI
Scryb Inc. Announces New Contract Win for Cybeats Technologies Corp CI
Scryb Inc. agreed to Spin-Off of a minority stake in Cybeats Technologies Corp. (OTCPK:RAEW.F). CI
- Scryb's Inc. Brief: Reporting Pima Zinc. Receives Conditional Approval to List on CSE; Pima Linked To Scryb's Partner Cybeats MT
Scryb Announces Partnership Between Cybeats and Veracode CI
More news
1 week-16.67%
Current month-16.67%
1 month-16.67%
3 months+25.00%
6 months-37.50%
Current year+25.00%
More quotes
1 week
0.02
Extreme 0.02
0.03
1 month
0.02
Extreme 0.02
0.04
Current year
0.02
Extreme 0.02
0.04
1 year
0.02
Extreme 0.02
0.15
3 years
0.02
Extreme 0.02
0.47
5 years
0.00
Extreme 0
0.93
10 years
0.00
Extreme 0
0.93
More quotes
Managers TitleAgeSince
Chief Executive Officer - 18-12-12
President - 18-01-04
Director of Finance/CFO - 14-12-31
Members of the board TitleAgeSince
Director/Board Member 63 19-03-31
Director/Board Member - 14-07-08
President - 18-01-04
More insiders
Date Price Change Volume
24-04-19 0.03 +20.00% 481 000
24-04-18 0.025 +25.00% 100,000
24-04-17 0.02 -33.33% 1,871,547
24-04-16 0.03 0.00% 295,700
24-04-15 0.03 0.00% 49,449

Delayed Quote Canadian Securities Exchange, April 18, 2024 at 09:42 am EDT

More quotes
Scryb Inc. is a technology company, which provides its platform to power businesses and technologies with applied intelligence, real-time analytics, and actionable insights. Its platform enables customers across industries to create, enhance and power disruptive solutions. Its technology includes Cybeats, Fionet and Pharmatrac. Cybeats is an integrated security platform designed to secure and protect connected devices. Cybeats approach eliminates device downtime due to cyber-attacks and allows device manufacturers to develop and maintain secure and protected devices. Fionet Platform is an end-to-end, rapid testing and tracking solution for community-based or decentralized settings. Fionet Platform handles scheduling and registration via phone app at home, on-site check-in, rapid, on-the-spot antigen testing and anonymized data and stats for dashboards for authorized stakeholders. Pharmatrac is an artificial intelligence healthcare company that provides insight into medication behavior.
More about the company

Quarterly revenue - Rate of surprise